TGen News & Press Releases

Researchers detail changes in the blood-brain barrier related to Alzheimer’s disease

Posted Friday February 24, 2023

The brain tissue grows and accumulates abnormal inflammatory signals

Phone app guides healthy rotation of insulin pumps, sensors

Posted Wednesday January 18, 2023

pilot study tests how type 1 diabetes patients can use app to avoid skin complications

PepSeq Provides Massive Platform for Antibody Analyses

Posted Monday December 5, 2022

Technology developed at TGen described in new study

MindCrowd 2.0 Launches with New Brain Games, Smartphone Access

Posted Wednesday July 20, 2022

One-of-a-kind online study looks for ways to reduce cognitive decline as we age

COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses

Posted Tuesday July 5, 2022

Technology developed by TGen researchers could help fine-tune future vaccines

Circulating Tumor DNA Guides Chemotherapy Use in Stage II Colon Cancer

Posted Saturday June 4, 2022

Researchers from TGen, a part of City of Hope, contribute to study supporting value of ctDNA in assessing treatment options

TGen study offers path for late-stage cancer patients wanting to leverage their own health data to guide their care

Posted Wednesday May 18, 2022

Prev
1
[2]
Next

Media Contact

Galen Perry
[email protected]
602-343-8423

Newsletter

News Archive

View Media Release Archive

OnCline

TGen is a partner with OncLive

Latest Posts

TGen gains early access to Illumina Protein Prep October 03, 2024
TGen Named Certified Service Provider for PacBio September 24, 2024
TGen Fashions a Future Without Cancer September 23, 2024

Useful Links

Contact Us

TGen headquarters
445 N. Fifth Street
Phoenix, AZ 85004
Phone: 602.343.8400
Toll Free: +1-866-370-8436

Stay up-to-date with TGen

2024 © All Rights Reserved TGen. Registered 501(c)(3). EIN: 75-3065445